Pluripotent stem cell-based drug discovery uncovers sildenafil as a treatment for mitochondrial disease
Zink, A.; Dai, D.-F.; Wittich, A.; Henke, M.-T.; Pedrotti, G.; Heiduschka, S.; Aguilar, G. S.; Pentimalli, T. M.; Brueser, C.; Notopoulou, S.; Zhaivoron, A.; Umar, A. R.; Petersilie, L.; Jerred, C.; Bergmans, J.; Schumacher, F.; Keller-Findeisen, J.; Rybak-Wolf, A.; Stach, D.; Reinshagen, J.; Zaliani, A.; Haferkamp, U.; Euro, L.; Di Donfrancesco, A.; Santanatoglia, C.; Cappellozza, E.; Suarez Cubero, M.; Pavez-Giani, M.; Bakumenko, O.; Meierhofer, D.; Foley, A.; Morales-Gonzalez, S.; Tolle, I.; Herebian, D.; Bonesso, D.; Szabo, I.; Cecchetto, G.; Nagumo Wong, S.; Moresco, M.; Maresca, A.; Deci
Show abstract
Mitochondrial disease encompasses inherited disorders affecting mitochondrial function. A severe and untreatable form of mitochondrial disease is Leigh syndrome (LS) causing psychomotor regression and metabolic crises. To accelerate drug discovery for LS, we screened a library of 5,632 repurposable compounds in induced pluripotent stem cell (iPSC)-derived neural progenitor cells (NPCs) from LS patients. We identified phosphodiesterase 5 inhibitors (PDE5i) as leads, and prioritized sildenafil due to its safety profile. Sildenafil restored pathways regulating nervous system development, enhanced neurite outgrowth in LS neurons, and mitigated abnormal calcium responses in LS brain organoids under metabolic stress. In a mouse model of LS, sildenafil extended the lifespan and ameliorated metabolic and encephalopathy phenotypes. Chronic off-label compassionate treatment with sildenafil in six LS patients showed improvements in motor function and resistance to metabolic crises. These findings highlight the potential of iPSC-driven drug discovery and position sildenafil as a promising candidate for mitochondrial diseases.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Mutant Huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure 96%
- Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia 96%
- Reliability of high-quantity human brain organoids for modeling microcephaly, glioma invasion, and drug screening 96%
Similar papers in this journal
- Electron transport inhibition increases cellular dependence on purine transport and salvage 95%
- A human omentum-specific mesothelial-like stromal population inhibits adipogenesis through IGFBP2 secretion 94%
- Integrative genetic analysis identifies FLVCR1 as an essential component of choline transport in mammals 94%
Similar papers in this journal
- Electrophysiological measures from human iPSC-derived neurons are associated with schizophrenia clinical status and predict individual cognitive performance 95%
- S-Nitrosylation of CRTC1 in Alzheimer's disease impairs CREB-dependent gene expression induced by neuronal activity 95%
- PGC-1a drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.